概括
腹痛是一种复杂的运动障碍. 早期识别它的迹象和症状对于准确的诊断和有效的治疗至关重要,包括新的疗法和管理非运动症状.
科学领域:
- 神经学 神经学
- 运动障碍 运动障碍
背景情况:
- 脊髓炎是一种异质的运动障碍,可以是其他神经疾病的初级条件或次要条件.
- 由于缺乏特定的生物标志物,准确的诊断具有挑战性,这强调了临床识别的重要性.
研究的目的:
- 审查流行病学,诊断标准,临床特征和 dystonia 的治疗.
- 讨论当前的争议和新兴的方面,在dystonia管理.
主要方法:
- 文献综述侧重于流行病学,诊断,临床表现和 dystonia 的治疗选择.
- 对最近分类和治疗方式方面的进展进行分析.
主要成果:
- 诊断抑郁症依赖于仔细的临床评估和特征性迹象的识别.
- 治疗领域包括神经刺激和肉毒素注射,人们越来越关注疼痛和情绪障碍等非运动性症状.
结论:
- 准确及时诊断 dystonia 对于有效管理至关重要.
- 随着 dystonia 的不断变化的理解,需要更新的分类系统和全面的治疗策略,以解决运动和非运动方面的问题.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
762
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
762
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
622
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
622
Skeletal Muscle Relaxants: Adverse Effects
474
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
474
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
533
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
533
Parkinson's Disease: Overview
710
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
710


